Recent clinical successes, and profits, have prompted a rush among pharma companies to try new isotopes and targeting strategies
Last updated: February 28, 2026 12:22 PM
Recent clinical successes, and profits, have prompted a rush among pharma companies to try new isotopes and targeting strategies